Stay updated on CM-24 Combo Study With Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the CM-24 Combo Study With Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CM-24 Combo Study With Pembrolizumab Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3. This update does not change the study details or site content.
    Difference
    0.0%
    Check dated 2026-03-07T19:08:09.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Gastric cancer was added to the list of studied conditions and a Genetics/Rare Diseases Information Center resource was included. The page revision was updated from v3.4.1 to v3.4.2.
    Difference
    0.2%
    Check dated 2026-02-14T08:28:26.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision: v3.4.1 was added and v3.4.0 was removed. This change does not affect study data, eligibility, or functionality; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-07T06:20:15.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page now includes a glossary toggle (Show glossary) and displays a new 'Last Update Submitted that Met QC Criteria' indicator, along with a site revision note 'Revision: v3.4.0'. The previous elements 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.
    Difference
    0.2%
    Check dated 2026-01-24T01:40:00.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision tag updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-16T23:27:10.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Added a consolidated Locations section with California and Connecticut; removed the separate California Locations and Connecticut Locations sections and the HHS Vulnerability Disclosure footer, and updated the revision to v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-19T10:31:53.000Z thumbnail image

Stay in the know with updates to CM-24 Combo Study With Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CM-24 Combo Study With Pembrolizumab Clinical Trial page.